Nanoparticle Vaccines Against Infectious Diseases.

Area of Science:

• Immunology and Vaccinology
• Materials Science and Nanotechnology
• Infectious Disease Research

Background:

• Emerging microbial variants present significant challenges for current infectious disease treatments and immunizations.
• Traditional vaccines (subunit, killed, live-attenuated) have limitations, including potential pathogenicity regain and variable efficacy.
• There is a critical need for risk-free, effective vaccines with advanced delivery systems to induce robust humoral and cell-mediated immunity.

Purpose of the Study:

• To review the application of nanoparticle-based vaccine formulations for improved vaccine efficacy.
• To explore strategies for functionalizing nanoparticles for efficient vaccine delivery.
• To highlight the role of nanocarriers in achieving desired host immunity against infectious diseases.

Main Methods:

• Review of current literature on nanoparticle-based vaccine development.
• Analysis of physicochemical properties of nanoparticles relevant to vaccine efficacy.
• Examination of functionalization strategies for nanocarriers in vaccine delivery.

Main Results:

• Nanoparticle-based vaccines show great potential for enhancing vaccine efficacy and immunization strategies.
• Nanocarriers can protect antigens, facilitate antigen uptake by antigen-presenting cells, and control drug release.
• Various nanocarrier materials (lipids, proteins, metals, polymers) have demonstrated utility in vaccine formulations.

Conclusions:

• Nanoparticle-based vaccines are a crucial advancement in combating infectious diseases caused by new microbial variants.
• Functionalized nanoparticles offer a versatile platform for targeted vaccine delivery and enhanced immune responses.
• Further research into nanocarrier properties and functionalization is essential for optimizing next-generation vaccines.